Tissue Regenix Group PLC (TRX)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
7.00p
Buy
7.50p
0.00p (+0.00%)
Prices updated at 22 Oct 2025, 13:24 BST
| Prices minimum 15 mins delay
Prices in GBX
Tissue Regenix Group PLC is a biotechnology company. Its business includes the development of regenerative products using its dcell technology.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 26m | 29m | |
| 13m | 14m | |
| -614,000 | 473,000 | |
| -2.33 | 1.65 | |
| -2m | -713,000 | |
| -22,000 | 1m | |
| Sales, General and administrative | 14m | 13m |
| Interest expenses | 890,000 | 882,000 |
| Provision for income taxes | -12,000 | 289,000 |
| Operating expenses | 14m | 13m |
| Income before taxes | -2m | -564,000 |
| Net income available to common shareholders | -2m | -713,000 |
| -0.0243 | -0.01 | |
| Net interest income | -1m | -913,000 |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.0243 | -0.01 |
| Free cash flow per share | -0.0244 | -0.0072 |
| Book value/share | 0.3419 | 0.3361 |
| Debt equity ratio | 0.290315 | 0.330494 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 19m | 21m |
| Current liabilities | 5m | 6m |
| Total capital | 36m | 40m |
| Total debt | 9m | 10m |
| Total equity | 30m | 30m |
| Total non current liabilities | - | - |
| Loans | 6m | 10m |
| Total assets | 43m | 45m |
| Total liabilities | - | - |
| Cash and cash equivalents | 5m | 2m |
| Common stock | 70m | 71m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 6m | 5m |
| Cash dividends paid | - | - |
| 177,000 | -6m | |
| Investments (gains) losses | -837,000 | -4m |
| 5m | 2m | |
| Net income | - | - |
| 1m | -2m | |
| -863,000 | -4m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
